Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen

The recombinant human monoclonal antibody (MAb) against hepatitis B virus (HBV) surface antigen (HBsAg) was expressed in tobacco suspension cultures. The parental CL4MAb was produced by the Epstein–Barr virus (EBV) transformed human cell line TAPC301‐CL4. The CL4MAb cDNA was introduced into tobacco suspension cells by Agrobacterium mediated transformation. The monoclonal antibodies (MAbs), B294 and B303, which were derived from CL4 and subsequently produced in plant cells were selected for study. After purification on Protein A columns, B294 and B303 MAbs had anti‐HBs relative affinity constants similar to the parental CL4MAb. B303 MAb interacted with cell surface HBsAgs and showed complement‐dependent cytotoxicity in a manner that was similar to anti‐HBs human immunoglobulins (HBIg) that are used clinically. The results of this study point to the feasibility of producing MAbs to HBsAg in plants as an alternative to HBIg. J. Med. Virol. 73:208–215, 2004. © 2004 Wiley‐Liss, Inc.

[1]  P. Lerouge,et al.  Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Y. Masuho,et al.  Human monoclonal antibodies neutralizing human cytomegalovirus. , 1987, The Journal of general virology.

[3]  P. Mullineaux,et al.  Effect of two consensus sequences preceding the translation initiator codon on gene expression in plant protoplasts , 1992, Plant Molecular Biology.

[4]  W. Stiekema,et al.  Expression of biologically active hordothionins in tobacco. Effects of pre- and pro-sequences at the amino and carboxyl termini of the hordothionin precursor on mature protein expression and sorting , 2004, Plant Molecular Biology.

[5]  F. Hsieh,et al.  Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Double‐Blind, Placebo‐Controlled Trial , 2007, Hepatology.

[6]  M. Hein,et al.  Immunotherapeutic potential of antibodies produced in plants. , 1995, Trends in biotechnology.

[7]  N. Raikhel,et al.  The Specificity of Vesicle Trafficking: Coat Proteins and SNAREs , 1999, Plant Cell.

[8]  F. Breedveld,et al.  Therapeutic monoclonal antibodies , 2000, The Lancet.

[9]  M. Kane,et al.  New immunization initiatives and progress toward the global control of hepatitis B , 2002, Current opinion in infectious diseases.

[10]  E. Davidov,et al.  Advancing drug discovery through systems biology. , 2003, Drug discovery today.

[11]  C. V. van Dolleweerd,et al.  A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice , 2000, Transgenic Research.

[12]  E. Keeffe,et al.  Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties , 2002, Hepatology.

[13]  K. Adler,et al.  Calreticulin expression in plant cells: developmental regulation, tissue specificity and intracellular distribution , 1998, Planta.

[14]  D W Galbraith,et al.  Green-fluorescent protein as a new vital marker in plant cells. , 1995, The Plant journal : for cell and molecular biology.

[15]  P. Lerouge,et al.  The protein N-glycosylation in plants , 1998 .

[16]  T. Nagata,et al.  Delivery of tobacco mosaic virus RNA into plant protoplasts mediated by reverse-phase evaporation vesicles (Liposomes) , 1981, Molecular and General Genetics MGG.

[17]  R. Twyman,et al.  Production of antibodies in plants and their use for global health. , 2003, Vaccine.

[18]  A. Casadevall,et al.  Serum therapy revisited: animal models of infection and development of passive antibody therapy , 1994, Antimicrobial Agents and Chemotherapy.

[19]  Y. Kimura.  Expression of human b1,4-galactosyltransferase gene modifies N- glycosylation pattern in tobacco BY2 cells. , 1999 .

[20]  V. Zurawski,et al.  Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D R Burton,et al.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Datla,et al.  Modified binary plant transformation vectors with the wild-type gene encoding NPTII. , 1992, Gene.

[23]  G. An,et al.  High efficiency transformation of cultured tobacco cells. , 1985, Plant physiology.

[24]  U. Conrad,et al.  Compartment-specific accumulation of recombinant immunoglobulins in plant cells: an essential tool for antibody production and immunomodulation of physiological functions and pathogen activity , 1998, Plant Molecular Biology.

[25]  F. Mahoney,et al.  Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection , 1999, Clinical Microbiology Reviews.

[26]  M. Keller,et al.  Passive immunity in prevention and treatment of infectious diseases. , 2000, Clinical microbiology reviews.

[27]  Roger Williams,et al.  Endocytosis of Hepatitis B Immune Globulin into Hepatocytes Inhibits the Secretion of Hepatitis B Virus Surface Antigen and Virions , 2003, Journal of Virology.

[28]  P. Sojikul,et al.  A plant signal peptide–hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  I. Raskin,et al.  Plants and human health in the twenty-first century. , 2002, Trends in biotechnology.

[30]  S. Yoshida,et al.  Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T Burnouf,et al.  Reducing the risk of infection from plasma products: specific preventative strategies. , 2000, Blood reviews.

[32]  J. Denecke,et al.  The Endoplasmic Reticulum—Gateway of the Secretory Pathway , 1999, Plant Cell.

[33]  C. Wittekind,et al.  Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. , 1991, Journal of hepatology.

[34]  I. Raskin,et al.  Production of recombinant proteins in plant root exudates , 1999, Nature Biotechnology.